---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-065598"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:45:29.665662+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# FOXO narrows Q2 loss to $0.49 EPS; capital structure streamlined, raises ~$260K in private placement

## Summary
- Basic EPS loss of $0.49 in Q2 2023 vs $3.84 loss a year ago; diluted loss $0.83 vs $6.01.
- Adjusted EBITDA loss improved to $3.34M in Q2 from $8.82M in prior-year quarter; six-month loss $7.20M.
- Completed two tender offers: 1.65M warrants exchanged for 7.96M shares; 4.32M shares issued to PIK note holders.
- Raised ~$260K net proceeds from private placement of 5.625M shares of Class A common stock.
- Launched Bioinformatics Services in July 2023; paused Longevity Report beta sales for further R&D.

## SEC filing metadata
- accession: 0001213900-23-065598
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000121390023065598/0001213900-23-065598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000121390023065598/ea183281-8k_foxotech.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-065598
- JSON: https://secwatch.observer/filing/0001213900-23-065598.json
- Plain text: https://secwatch.observer/filing/0001213900-23-065598.txt

## Key facts
- Earnings Releases
  FOXO TECHNOLOGIES INC. reported second quarter ended June 30, 2023 results: EPS $(0.49) and $(0.83) for the three and six months ended June 30, 2023, respectively from $(3.84) and $(6.01) for the thre.
  - Period: second quarter ended June 30, 2023
  - EPS: $(0.49) and $(0.83) for the three and six months ended June 30, 2023, respectively from $(3.84) and $(6.01) for the thre
  - Result: reported results
  source text: FOXO Technologies Inc. (NYSEAM: FOXO), a leader in the field of commercializing epigenetic biomarker technology, today reported financial results for the second quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812360/000121390023065598/0001213900-23-065598-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.